Who is ACGT?

WHO is ACGT? Alliance for Cancer Gene Therapy (ACGT) is the only charitable research foundation focusing specifically on funding the advancement of cancer cell and gene therapies.

WHAT does ACGT do? Our mission is to fund the most innovative scientists and biotechnology companies working to harness the power of cell and gene therapy to transform how cancer is treated and to drive momentum toward a cure.

WHY? ACGT believes that these new therapies will improve cancer cure rates, reduce or eliminate short- and long-term side effects and drive a paradigm shift in how cancer is treated, away from surgery and toxic chemotherapy and radiation.

HOW does ACGT use donations? 100% of all public donations go directly to fund research. We engage the unparalleled ACGT Scientific Advisory Council (SAC) to identify and fund the very best research projects that will expedite cancer cell and gene therapies.


Scientific Advisory Council

Joseph C. Glorioso III, PhD, Council Chair
University of Pittsburgh

Stuart A. Aaronson, MD
Mount Sinai School of Medicine

John C. Bell, PhD
Ottawa Hospital Research Institute

Lieping Chen, MD, PhD
Yale Cancer Center

Antonio Chiocca, MD, PhD
Brigham and Women’s Hospital

Mitchell H. Finer, PhD
MPM Capital

Carl H. June, MD
University of Pennsylvania

Noriyuki Kasahara, MD, PhD
University of California, San Francisco

Michael T. Lotze, MD
University of Pittsburgh

Jack A. Roth, MD, FACS
MD Anderson Cancer Center

Stephen J. Russell, MD, PhD
Mayo Clinic

Michel Sadelain, MD, PhD
Memorial Sloan Kettering Cancer Center

Dario Vignali, PhD
University of Pittsburgh

George D. Yancopoulos, MD, PhD
Regeneron Pharmaceuticals

Savio L. C. Woo, PhD, Chair Emeritus
Mount Sinai School of Medicine, retired

ACGT Research Fellows*

Alliance for Cancer Gene Therapy, Inc. funds research aimed at furthering the development of cell and gene therapy approaches to the treatment of cancer. Grants are competitively awarded in the amount of $250,000 – $1,000,000 to innovative researchers in the United States and Canada upon rigorous peer-review and recommendations made by the ACGT Scientific Advisory Council. To be added to ACGT’s RFA distribution list, please email contact information to info@acgtfoundation.org

Through 2019, ACGT has awarded 59 grants to 57 researchers at 33 unique institutions totaling $30.2 million.

 

Nabil Ahmed, MD, MPH (2011)
Baylor College of Medicine, Brain Cancer

Arnob Banerjee, MD, PhD (2014)
University of Maryland School of Medicine, Blood Cancer

Jeffrey S. Bartlett, PhD (2003)
The Research Institute at the National Children’s Hospital, Ovarian Cancer

John Bell, PhD (2014)
Ottawa Hospital Research Institute, Brain Cancer

Roberto Cattaneo, PhD (2007)
Mayo Clinic College of Medicine, Lymphoma/Leukemia

Yvonne Chen, MS, PhD (2016)
University of California, Los Angeles, Lymphoma/Leukemia

Antonio E. Chiocca, MD, PhD (2008)
Harvard Medical School, Brain Cancer

Laurence Cooper, MD, PhD (2004)
University of Texas, MD Anderson Cancer Center, Lymphoma/Leukemia

George Coukos, MD, PhD (2006)
University of Pennsylvania Abramson Cancer Center, Ovarian/Peritoneal Cancer

Andrew M. Davidoff, MD (2003)
St. Jude Children’s Research Hospital, Neuroblastoma

Greg Delgoffe, PhD (2017)
University of Pittsburgh School of Medicine, Melanoma

Glenn Dranoff, MD (2011)
Dana Farber/ Harvard Cancer Center, Leukemia

Joseph A. Fraietta, PhD (2019)
University of Pennsylvania Abramson Cancer Center, Prostate

Marco Gallo, PhD (2017)
University of Calgary, Brain

Joseph C. Glorioso, PhD (2018)
University of Pittsburgh School of Medicine, Melanoma

Stephen Gottschalk, MD (2019)
St. Jude Children’s Research Hospital, Sarcoma

Thomas S. Griffith, PhD (2003)
University of Minnesota, Prostate Cancer

Brent Hanks, MD, PhD (2016)
Duke University Medical Center, Melanoma

Biao He, PhD (2006)
University of Georgia, Breast Cancer

Meenakshi Hegde, MD (2015)
Baylor College of Medicine, Melanoma

Hui Hu, PhD (2012)
University of Alabama, Ovarian Cancer 

Chien-Fu Hung, PhD (2005)
Johns Hopkins University School of Medicine, Ovarian Cancer

Mukesh Jain, MD, FAHA (2005)
Case Western Reserve University, Metastatic Cancer

Christopher Jewell, PhD (2015)
University of Maryland, College Park, Lymphatic Systems

Carl H. June, MD (2004, 2008)
University of Pennsylvania Abramson Cancer Center, Lymphoma/Leukemia, Ovarian

Noriyuki Kasahara, MD, PhD (2017)
University of Miami, Glioblastoma

Samuel G. Katz, MD, PhD (2016)
Yale University Medical School, Solid Tumors

Thomas J. Kipps, MD, PhD (2005, 2010)
Moores Cancer Center, University of California, San Diego, Lymphoma/Leukemia

Timothy Lane, PhD (2004)
University of California, Los Angeles, Breast Cancer

Maciej S. Lesniak, MD (2007)
University of Chicago, Brain Cancer

Hyam I. Levitsky, MD (2005)
Johns Hopkins University School of Medicine, Lymphoma/Leukemia

Ronald Levy, MD (2008)
Stanford University, Lymphoma

Michael Z. Lin, MD, PhD (2011)
Stanford University, Brain/Breast Cancer

Crystal Mackall, MD (2016)
Stanford University School of Medicine, Osteosarcoma

Douglas Mahoney, PhD (2013)
University of Calgary, Breast Cancer

Clodagh O’Shea, PhD (2008)
Salk Institute for Biological Studies, Breast Cancer

Kah-Whye Peng, PhD (2007)
Mayo Clinic Cancer Center, Multiple Myeloma

Eckhard Podack, MD, PhD (2006)
University of Miami Miller School of Medicine, Lung Cancer

Seth Pollack, MD (2018)
Fred Hutchinson Cancer Research Center, Sarcoma

Daniel Powell, PhD (2018)
University of Pennsylvania Abramson Cancer Center, Ovarian

Suzie Pun, PhD (2005)
University of Washington, Metastatic Cancer

Todd R. Reilly, PhD (2003)
Johns Hopkins University, Breast Cancer

Katherine Ryman, PhD (2004)
University of Pittsburgh, Center for Vaccine Research, Prostate Cancer

Michel Sadelain, MD, PhD (2004)
Memorial Sloan Kettering Cancer Center, Lymphoma/Leukemia

Harald Sauthoff, MD (2007)
New York University, Breast/Lung Cancer

Miguel Sena-Esteves, PhD (2006)
University of Massachusetts Medical School, Brain Cancer

Khalid Shah, PhD, MSc (2008)
Harvard Medical School, Massachusetts General Hospital, Brain Cancer

Alexander Stegh, PhD (2013)
Northwestern University, Brain Cancer

Matthias Stephan, MD (2018)
Fred Hutchinson Cancer Research Center, Ovarian

Koji Tamada, MD, PhD (2006)
University of Maryland, Lymphatic Systems

Steve Thorne, PhD (2009)
University of Pittsburgh, Breast/Ovarian Cancer

Robert Vonderheide, MD, DPhil (2004)
University of Pennsylvania Abramson Cancer Center, Neuroblastoma

Fan Yang, PhD (2014)
Stanford University School of Medicine, Brain Cancer

Yiping Yang, MD, PhD (2005)
Duke University Medical Center, Lymphoma/Leukemia

Jian Yu, PhD (2005)
University of Pittsburgh School of Medicine, Hillman Cancer Center, Lung Cancer

Herbert J. Zeh, III, MD, FACS (2012)
University of Pittsburgh, Pancreatic Cancer

Xianzheng Zhou, MD, PhD (2006)
New York Medical College, Lymphoma/Leukemia

 

* Institutions listed reflect the researcher’s association at the time of the award.